These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2304479)

  • 1. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 10. A new approach to germinal mutation surveillance: pair-wise evaluation of component elements in unidentified multiple congenital abnormalities.
    Kis-Varga A; Rudas T; Czeizel A
    Mutat Res; 1990 Jan; 238(1):87-97. PubMed ID: 2304479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of legal abortions and congenital abnormalities in Hungary.
    Czeizel AE
    Biomed Pharmacother; 1991; 45(6):249-54. PubMed ID: 1912381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC working paper no. 4. Mutation surveillance of sentinel anomalies in Hungary, 1980-1984.
    Czeizel A; Kis-Varga A
    Mutat Res; 1987 Jul; 186(1):73-9. PubMed ID: 3600685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hungarian surveillance of germinal mutations. Lack of detectable increase in indicator conditions caused by germinal mutations following the Chernobyl accident.
    Czeizel A
    Hum Genet; 1989 Jul; 82(4):359-66. PubMed ID: 2525516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population surveillance of sentinel anomalies.
    Czeizel A
    Mutat Res; 1989 May; 212(1):3-9. PubMed ID: 2524663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of the germinal mutagenic impact of Chernobyl radiological contamination in Hungary.
    Czeizel AE; Elek C; Susánszky E
    Mutagenesis; 1991 Jul; 6(4):285-8. PubMed ID: 1834914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 5/6. Perspectives in mutation epidemiology, 6. A 1983 view of sentinel phenotypes.
    Mulvihill JJ; Czeizel A
    Mutat Res; 1983 Dec; 123(3):345-61. PubMed ID: 6358880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activities of the Hungarian Centre for Congenital Anomaly Control.
    Czeizel A
    World Health Stat Q; 1988; 41(3-4):219-27. PubMed ID: 2976555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital abnormalities and indicators of germinal mutations in the vicinity of the Paks nuclear plant, Hungary.
    Siffel C; Otos M; Czeizel AE
    Mutagenesis; 1996 May; 11(3):299-303. PubMed ID: 8671752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/1: Perspectives in mutation epidemiology. 1. Incidence and prevalence of genetic disease (excluding chromosomal aberrations) in human populations.
    Matsunaga E
    Mutat Res; 1982 Jul; 99(1):95-128. PubMed ID: 6289095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family study of cases with unidentified multiple congenital abnormality.
    Czeizel A
    Acta Paediatr Hung; 1988-1989; 29(3-4):317-29. PubMed ID: 3269268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 50 years of the Hungarian Congenital Abnormality Registry.
    Czeizel AE; Métneki J; Béres J
    Congenit Anom (Kyoto); 2014 Feb; 54(1):22-9. PubMed ID: 24588776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital abnormalities and indicators of germinal mutations in the vicinity of an acrylonitrile producing factory.
    Czeizel AE; Hegedüs S; Tímár L
    Mutat Res; 1999 Jun; 427(2):105-23. PubMed ID: 10393265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidimensional threshold model for multiple congenital abnormalities.
    Czeizel A; Telegdi L; Tusnády G
    Acta Paediatr Hung; 1986; 27(3):189-204. PubMed ID: 3778668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive congenital anomaly patterns.
    Czeizel A
    Am J Med Genet; 1988 Apr; 29(4):727-38. PubMed ID: 3400719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/4. Perspectives in mutation epidemiology: 4. General principles and considerations.
    Miller JR
    Mutat Res; 1983 Apr; 114(3):425-47. PubMed ID: 6835244
    [No Abstract]   [Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
    Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
    Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unidentified multiple congenital abnormalities in twins. A population-based Hungarian study.
    Métneki J; Pazonyi I; Czeizel A
    Acta Paediatr Hung; 1992; 32(3):203-17. PubMed ID: 1476780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
    Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.